APPENDIX C - DRUG-FREE WORKPLACE CERTIFICATION
INSTRUCTIONS FOR CERTIFICATION
1. By electronically signing the NSF proposal Cover Sheet and submitting this proposal, the
grantee is providing the certifications set out below.
2. The certification set out below is a material representation of fact upon which reliance was placed when the agency determined to award the grant. If it is later determined that the grantee knowingly rendered a false certification, or otherwise violates the requirements of the Drug-Free Workplace Act, the agency, in addition to any other remedies available to the Federal Government, may take action authorized under the Drug-Free Workplace Act.
3. For grantees other than individuals, Alternate I applies.
4. For grantees who are individuals, Alternate II applies.
CERTIFICATION REGARDING DRUG-FREE WORKPLACE REQUIREMENTS
Alternate I (Grantees Other Than Individuals)
The grantee certifies that it will or will continue to provide a drug-free workplace by:
(a) Publishing a statement notifying employees that the unlawful manufacture, distribution,
dispensing, possession or use of a controlled substance is prohibited in the grantee's
workplace and specifying the actions that will be taken against employees for violation of such
(b) Establishing an ongoing drug-free awareness program to inform employees about --
- The dangers of drug abuse in the workplace;
- The grantee's policy of maintaining a drug-free workplace;
- Any available drug counseling, rehabilitation and employee assistance programs; and
- The penalties that may be imposed upon employees for drug abuse violations occurring in the workplace;
(c) Making it a requirement that each employee to be engaged in the performance of the
grant be given a copy of the statement required by paragraph (a);
(d) Notifying the employee in the statement required by paragraph (a) that, as a condition
of employment under the grant, the employee will --
- Abide by the terms of the statement; and
- Notify the employer in writing of his or her conviction for a violation of a criminal drug
statute occurring in the workplace, no later than five calendar days after such conviction;
(e) Notifying the agency in writing, within 10 calendar days after receiving notice under
subparagraph (d)(2) from an employee or otherwise receiving actual notice of such conviction.
Employers of convicted employees must provide notice, including position title, to every
grant officer or other designee on whose grant activity the convicted employee was working,
unless the Federal agency has designated a central point for the receipt of such notices.
Notice shall include the identification number(s) of each affected grant;
(f) Taking one of the following actions, within 30 calendar days of receiving notice under
subparagraph (d)(2), with respect to any employee who is so convicted--
- Taking appropriate personnel action against such an employee, up to and
including termination, consistent with the requirements of the Rehabilitation Act of 1973, as
- Requiring such employee to participate satisfactorily in a drug abuse assistance or
rehabilitation program approved for such purposes by a Federal, State, or local health, law
enforcement, or other appropriate agency;
(g) Making a good faith effort to continue to maintain a drug-free workplace through
implementation of paragraphs (a), (b), (c), (d), (e) and (f).
Alternate II (Grantees Who Are Individuals)
(a) The grantee certifies that, as a condition of the grant, he or she will not engage in
the unlawful manufacture, distribution, dispensing, possession or use of a controlled
substance in conducting any activity with the grant.
(b) If convicted of a criminal drug offense resulting from a violation occurring during
the conduct of any grant activity, he or she will report the conviction, in writing, within 10
calendar days of the conviction, to every grant officer or other designee, unless the Federal
agency designates a central point for the receipt of such notices. When notice is made to
such a central point, it shall include the identification number(s) of each affected grant.
(For NSF, grantee notification should be made to the Cost Analysis/Audit Resolution Branch,
Division of Acquisition and Cost Support, NSF, Arlington, VA 22230)